Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-07-11

Clinical Trial Update: Comparative Study Between Topical 5-fluorouracil and Latanoprost in Vitiligo. [Phase 2, Phase 3]

View source ↗

Summary

A comparative Phase 2/Phase 3 trial examines topical 5-fluorouracil versus latanoprost for vitiligo; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Latanoprost (Latanoprost)
  • Topical 5-Fluorouracil (5-fluorouracil)

Snippet

Sponsor: South Valley University | Conditions: Vitiligo | Phase 2, Phase 3 | Status: COMPLETED